Generate Biomedicines, Inc. Balance Sheet
Generate Biomedicines, Inc.'s total assets for Q2 2026 were $561.69M, a decrease of -10.24% from the previous quarter. GENB total liabilities were $105.64M for the fiscal quarter, a -4.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.